Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms
In this article, we describe a patient with double-expressor diffuse large B-cell lymphoma with localized compression symptoms after second-line treatment failure who benefited from CAR-T combined with focal bridging radiotherapy.
Authors
- Ligang Xing (ORCID: https://orcid.org/0000-0002-0528-9048)
- Mengdi Wu
- Lijie Xing (ORCID: https://orcid.org/0000-0001-9737-0021)
- Liying Yang (ORCID: https://orcid.org/0000-0001-9211-0685)
- Jinming Yu (ORCID: https://orcid.org/0000-0001-7710-5466)
- Dan Liu (ORCID: https://orcid.org/0000-0003-3144-9401)
- Xiaorong Sun (ORCID: https://orcid.org/0000-0001-8520-9556)
- Hao Yang (ORCID: https://orcid.org/0009-0007-7437-1815)
Institutions
- Shandong University (CN)
- Shandong Tumor Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3389/fimmu.2024.1441404
- Citations
- 2
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Department of Science and Technology of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province